Metformin as an Upstream Substrate-Modifying Strategy for Atrial Fibrillation in Metabolic Dysfunction: Mechanistic Rationale and Clinical Evidence

Journal of Molecular Pathology · Published 2026-07-01 · DOI 10.3390/jmp7030025

Free full text

Authors (13)

Roopeessh Vempati, Christian Toquica Gahona, Fadi Haddad, Hari Vorappan Manickavelan, Faiza Zakaria, Julia Hanna, Muhammad Sanusi, Parjanya Bhatt, Rana Haddad, Fawaz Mohammed, Maneeth Mylavarapu, Yeruva Madhu Reddy, Rajiv Nair

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Vempati, R., Gahona, C., Haddad, F., et al. (2026). Metformin as an Upstream Substrate-Modifying Strategy for Atrial Fibrillation in Metabolic Dysfunction: Mechanistic Rationale and Clinical Evidence. Journal of Molecular Pathology. https://doi.org/10.3390/jmp7030025

Related articles